Letko, Brosseau & Associates’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $207M | Sell |
2,756,910
-153,174
| -5% | -$10.9M | 3.34% | 8 |
|
|
2025
Q4 | $180M | Sell |
2,910,084
-4,985
| -0.2% | -$293K | 2.94% | 12 |
|
|
2025
Q3 | $171M | Sell |
2,915,069
-27,694
| -0.9% | -$1.61M | 2.94% | 11 |
|
|
2025
Q2 | $171M | Sell |
2,942,763
-58,715
| -2% | -$3.32M | 3.27% | 8 |
|
|
2025
Q1 | $149M | Sell |
3,001,478
-85,462
| -3% | -$4.37M | 3.17% | 8 |
|
|
2024
Q4 | $138M | Buy |
3,086,940
+231,323
| +8% | +$11M | 2.67% | 12 |
|
|
2024
Q3 | $137M | Buy |
2,855,617
+211,804
| +8% | +$10.2M | 2.49% | 12 |
|
|
2024
Q2 | $135M | Buy |
2,643,813
+28,291
| +1% | +$1.55M | 2.55% | 12 |
|
|
2024
Q1 | $142M | Buy |
2,615,522
+282,485
| +12% | +$14.7M | 2.47% | 11 |
|
|
2023
Q4 | $132M | Buy |
2,333,037
+35,009
| +2% | +$1.98M | 2.41% | 12 |
|
|
2023
Q3 | $143M | Buy |
2,298,028
+163,619
| +8% | +$10.4M | 2.79% | 10 |
|
|
2023
Q2 | $126M | Sell |
2,134,409
-7,914
| -0.4% | -$504K | 2.35% | 13 |
|
|
2023
Q1 | $158M | Buy |
2,142,323
+19,048
| +0.9% | +$1.47M | 2.95% | 7 |
|
|
2022
Q4 | $155M | Sell |
2,123,275
-62,735
| -3% | -$4.96M | 2.79% | 9 |
|
|
2022
Q3 | $183M | Sell |
2,186,010
-32,966
| -1% | -$2.84M | 3.63% | 5 |
|
|
2022
Q2 | $176M | Sell |
2,218,976
-142,577
| -6% | -$13.8M | 3.12% | 8 |
|
|
2022
Q1 | $244M | Sell |
2,361,553
-794,141
| -25% | -$65.8M | 3.64% | 5 |
|
|
2021
Q4 | $238M | Sell |
3,155,694
-188,931
| -6% | -$13.2M | 3.4% | 5 |
|
|
2021
Q3 | $217M | Sell |
3,344,625
-285,396
| -8% | -$17.4M | 3.14% | 10 |
|
|
2021
Q2 | $220M | Sell |
3,630,021
-219,239
| -6% | -$13M | 2.93% | 11 |
|
|
2021
Q1 | $207M | Sell |
3,849,260
-980,603
| -20% | -$53.3M | 2.83% | 12 |
|
|
2020
Q4 | $232M | Sell |
4,829,863
-414,715
| -8% | -$18.3M | 3.18% | 11 |
|
|
2020
Q3 | $205M | Sell |
5,244,578
-318,869
| -6% | -$11.6M | 3.19% | 9 |
|
|
2020
Q2 | $178M | Sell |
5,563,447
-152,242
| -3% | -$5.3M | 2.63% | 11 |
|
|
2020
Q1 | $193M | Buy |
5,715,689
+2,820,584
| +97% | +$113M | 3.31% | 8 |
|
|
2019
Q4 | $139M | Buy |
2,895,105
+1,463,065
| +102% | +$70.7M | 1.38% | 24 |
|
|
2019
Q3 | $71.4M | Sell |
1,432,040
-9,565
| -0.7% | -$488K | 0.73% | 43 |
|
|
2019
Q2 | $77.3M | Sell |
1,441,605
-43,103
| -3% | -$2.25M | 0.78% | 41 |
|
|
2019
Q1 | $78.3M | Sell |
1,484,708
-123,286
| -8% | -$6.42M | 0.78% | 41 |
|
|
2018
Q4 | $75.5M | Sell |
1,607,994
-216,805
| -12% | -$11.3M | 0.84% | 40 |
|
|
2018
Q3 | $105M | Sell |
1,824,799
-162,899
| -8% | -$9.02M | 0.98% | 34 |
|
|
2018
Q2 | $108M | Sell |
1,987,698
-399,905
| -17% | -$19.8M | 0.99% | 36 |
|
|
2018
Q1 | $113M | Buy |
+2,387,603
| New | +$120M | 1.06% | 34 |
|
Other funds holding NTR
VCM
Letko, Brosseau & Associates's NTR Position: Q1 2026 in Review
Letko, Brosseau & Associates reduced its Nutrien (NTR) stake by 5.3% in Q1 2026, selling an estimated $10.9M and leaving 2,756,910 shares worth $207M. The position accounts for 3.34% of the portfolio, ranked #8.
Letko, Brosseau & Associates first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $244M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Letko, Brosseau & Associates held 2,756,910 shares of Nutrien worth $207M as of Q1 2026.
- Letko, Brosseau & Associates sold 153,174 Nutrien shares in Q1 2026, an estimated $10.9M.
- Nutrien made up 3.34% of Letko, Brosseau & Associates's portfolio in Q1 2026, its #8 holding.
- Letko, Brosseau & Associates first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Letko, Brosseau & Associates's Nutrien position peaked at $244M in Q1 2022.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.